ArticleCase reports in neurological medicine2026
Presentation of Neurological Rosai-Dorfman Disease Over 12 Years: A Case Report.
Article in Case reports in neurological medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Presentation of Neurological Rosai-Dorfman Disease Over 12 Years: A Case Report.Case reports in neurological medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rosai-Dorfman disease (RDD) is a rare, non-Langerhans cell histiocytosis that classically presents with cervical lymphadenopathy. Neurological involvement occurs in less than 5% of cases and is often associated with extra-axial lesions. Diagnosis of RDD in the setting of neurological deficits is challenging, as RDD often mimics meningioma and neurosarcoidosis on neuroimaging. Herein, we describe a case report of a 50-year-old African American man who was previously treated with radiation for presumed meningioma of the brainstem 12 years prior to the current presentation. The brainstem lesion progressed to include the pachymeninges despite radiation, and the patient developed papilledema and involvement of the bilateral cochlea. Lack of response to radiation, involvement of the pachymeninges, and development of papilledema and bilateral hearing loss led to an updated diagnosis of neurosarcoidosis. On current presentation, the patient was brought to the emergency department for altered mental status, seizures, and left-sided hemiparesis. Initial workup was negative for stroke, meningitis, and toxic or metabolic encephalopathies. Long-term electroencephalography confirmed seizures originating from the right frontal lobe, which was controlled with antiseizure medications. Magnetic resonance imaging revealed worsening diffuse brainstem and pachymeningeal enhancement of the bilateral cerebral convexities, suggesting progression of the disease. Workup for systemic malignancy revealed a hypodense soft tissue mass encasing the left kidney, raising concern for metastatic disease. Biopsy of the meninges and the renal mass confirmed RDD with multiorgan involvement. Diagnosis of RDD in this patient marks the longest duration from onset to diagnosis ever reported, indicating the need for tissue diagnostics in uncertain cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.